Corrigendum: LncRNA MSC-AS1 Is a Diagnostic Biomarker and Predicts Poor Prognosis in Patients With Gastric Cancer by Integrated Bioinformatics Analysis

Front Med (Lausanne). 2022 Feb 17:9:862010. doi: 10.3389/fmed.2022.862010. eCollection 2022.

Authors

Affiliations

¹ Department of General Surgery, The Affiliated Tumor Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China.
² Clinical Laboratory, The Children's Hospital of Henan Province, Zhengzhou Children's Hospital, The Affiliated Children Hospital of Zhengzhou University, Zhengzhou, China.

Abstract

[This corrects the article DOI: 10.3389/fmed.2021.795427.].

Keywords: bioinformatics; biomarker; gastric cancer; lncRNA MSC-AS1; prognosis.

Copyright © 2022 Yang, Ge, Lu, Shan, Peng, Chai, Liu, Li, Zhang, Huang, Hua and Zhang.

Publication types

Published Erratum